iBio
IBIO
#10072
Rank
S$90.85 M
Marketcap
S$1.83
Share price
2.14%
Change (1 day)
92.67%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.96. In 2025 the company made an earnings per share (EPS) of S-$2.24 an increase over its 2024 EPS that were of S-$8.31.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.64%
2025S-$2.24-73.08%
2024S-$8.31-93.88%
2023S-$135.81-8.14%
2022S-$147.8492.67%
2021S-$76.73-80.33%
2020S-$390.06-35.11%
2019S-$601.08-38.96%
2018S-$984.75-6.1%
2017S-$1,04936.67%
2016S-$767.3433.33%
2015S-$575.5150%
2014S-$383.67-53.85%
2013S-$831.29-7.14%
2012S-$895.23-64.1%
2011S-$2,49477.27%
2010S-$1,407144.44%
2009S-$575.5112.93%
2008S-$509.6212.2%
2007S-$454.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.17-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.67-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$10.77 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA